sport and news
Tuesday 24 May 2011
Oxford BioMedica Announces Presentation Of New Clinical Data From ProSavin(R) Phase I/II Study In Parkinson's Disease
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment